These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8623231)

  • 41. Liver transplantation followed by adjuvant nonmyeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humans.
    Söderdahl G; Barkholt L; Hentschke P; Mattsson J; Uzunel M; Ericzon BG; Ringdén O
    Transplantation; 2003 Apr; 75(7):1061-6. PubMed ID: 12698103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prospective analysis between the therapy of immunosuppressive medication and allogeneic microchimerism after liver transplantation.
    Araújo MB; Leonardi LS; Leonardi MI; Boin IF; Magna LA; Donadi EA; Kraemer MH
    Transpl Immunol; 2009 Jan; 20(3):195-8. PubMed ID: 18790055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunopathology of liver allografts and xenografts in nonhuman primates.
    Donato MF; Arosio E; Berti E; Gatti S; Piazzini A; Colledan M; Rossi G; Fassati LR; Galmarini D; Gridelli B
    Transplant Proc; 1993 Feb; 25(1 Pt 2):850-5. PubMed ID: 8442246
    [No Abstract]   [Full Text] [Related]  

  • 44. Induction of ICAM-1 on hepatocytes precedes the lymphoid activation of acute liver allograft rejection and cytomegalovirus infection.
    Lautenschlager I; Höckerstedt K
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1429-30. PubMed ID: 8095108
    [No Abstract]   [Full Text] [Related]  

  • 45. Donor cell population in the liver allograft reflects the recipient immune status.
    Meyer D; Löffeler S; Otto C; Gassel HJ; Timmermann W; Ulrichs K; Thiede A
    Transplant Proc; 1999; 31(1-2):437. PubMed ID: 10083177
    [No Abstract]   [Full Text] [Related]  

  • 46. Preformed antibodies detected by cytotoxic assay or multibead array decrease liver allograft survival: role of human leukocyte antigen compatibility.
    Castillo-Rama M; Castro MJ; Bernardo I; Meneu-Diaz JC; Elola-Olaso AM; Calleja-Antolin SM; Romo E; Morales P; Moreno E; Paz-Artal E
    Liver Transpl; 2008 Apr; 14(4):554-62. PubMed ID: 18383092
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility.
    Doxiadis II; de Fijter JW; Mallat MJ; Haasnoot GW; Ringers J; Persijn GG; Claas FH
    Transplantation; 2007 May; 83(9):1207-13. PubMed ID: 17496537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database.
    Navarro V; Herrine S; Katopes C; Colombe B; Spain CV
    Liver Transpl; 2006 Apr; 12(4):652-8. PubMed ID: 16555339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of positive cytotoxic cross-match in adult-to-adult living donor liver transplantation using small graft volume.
    Suh KS; Kim SB; Chang SH; Kim SH; Minn KW; Park MH; Han KS; Lee KU
    Liver Transpl; 2002 Dec; 8(12):1109-13. PubMed ID: 12474148
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K; John R; Beniaminovitz A; Burke EM; Suciu-Foca N; Mancini DM; Edwards NM; Itescu S
    Transplantation; 2003 Mar; 75(6):781-7. PubMed ID: 12660501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of HLA matching and associated factors on aortic valve homograft function.
    Dignan R; O'Brien M; Hogan P; Passage J; Stephens F; Thornton A; Harrocks S
    J Heart Valve Dis; 2000 Jul; 9(4):504-11. PubMed ID: 10947042
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
    Cecka JM
    Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Taboo HLA mismatches in cadaveric renal transplantation: definition, analysis, and possible implications.
    Doxiadis II; Smits JM; Stobbe I; Schreuder GM; Persijn GG; van Houwelingen H; van Rood JJ; Claas FH
    Transplant Proc; 1996 Feb; 28(1):224. PubMed ID: 8644189
    [No Abstract]   [Full Text] [Related]  

  • 57. Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease.
    Adamkiewicz TV; Mehta PS; Boyer MW; Kedar A; Olson TA; Olson E; Chiang KY; Maurer D; Mogul MJ; Wingard JR; Yeager AM
    Bone Marrow Transplant; 2004 Sep; 34(5):405-11. PubMed ID: 15247929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute cellular rejection following liver transplantation: clinical pathologic features and effect on outcome.
    Mor E; Solomon H; Gibbs JF; Holman MJ; Goldstein RM; Husberg BS; Gonwa TA; Klintmalm GB
    Semin Liver Dis; 1992 Feb; 12(1):28-40. PubMed ID: 1570549
    [No Abstract]   [Full Text] [Related]  

  • 59. The liver allograft, chronic (ductopenic) rejection, and microchimerism: what can they teach us?
    Demetris AJ; Murase N; Delaney CP; Woan M; Fung JJ; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):67-70. PubMed ID: 7879139
    [No Abstract]   [Full Text] [Related]  

  • 60. Severe ductopenic rejection following liver transplantation: incidence, time of onset, risk factors, treatment, and outcome.
    van Hoek B; Wiesner RH; Krom RA; Ludwig J; Moore SB
    Semin Liver Dis; 1992 Feb; 12(1):41-50. PubMed ID: 1570550
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.